Why the study?
Does whole-body scintigraphy using Tc-99m labeled Fab' antifibrin monoclonal antibody improve direct thrombus visualization compared to ventilation-perfusion scintigraphy in a patient with suspected pulmonary embolism?
Does whole-body scintigraphy using Tc-99m labeled Fab' antifibrin monoclonal antibody improve direct thrombus visualization compared to ventilation-perfusion scintigraphy in a patient with suspected pulmonary embolism?
Answers are grounded in this paper and cite their sources.
Direct thrombus visualization using Tc-99m labeled Fab' antifibrin monoclonal antibody can identify the heart as the origin of pulmonary emboli, showing significant differences compared to ventilation-perfusion scintigraphy.
A patient with shortness of breath had a high probability lung scan for pulmonary embolism, but no obvious embolic source. Whole-body scintigraphy using Tc-99m labeled Fab' antifibrin monoclonal antibody showed large central pulmonary emboli as well as tracer uptake in the right atrium and aortic arch. No lower extremity clot was detected. This case shows significant differences in the appearance of pulmonary embolism as assessed by direct clot and ventilation-perfusion scintigraphy. It shows the importance of the heart as the origin of pulmonary emboli and the utility of direct thrombus visualization.
No takes yet. Share an insight, caveat, or question.
Line et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: